Join
Live feed
·
FDARegulatoryvia Quantisnow
SRAX Inc. logo
Snap Inc. logo

November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

ByQuantisnow·Wall Street's wire, on your screen.
SRAX· SRAX Inc.SNAP· Snap Inc.
Consumer DiscretionaryTechnology
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRAX (SRAX Inc.), SNAP (Snap Inc.) and more on Quantisnow.